Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

Journal:

Journal of Clinical Oncology

Published:

2026-05-06

DOI:

10.1200/jco-25-02274

Affiliations:

28

Authors:

35

Go to article

Institutions	Authors	Share
Zealand University Hospital, Denmark	12.166667 12.166667	0.35
Aalborg University Hospital, Denmark	3.500000	0.10
Vejle Hospital, Denmark	2.500000	0.07
Regional Hospital in Horsens, Denmark	2.000000	0.06
Bispebjerg University Hospital (BBH), Denmark	2.000000	0.06
Odense University Hospital (OUH), Denmark	2.000000	0.06
Rigshospitalet, Denmark	1.500000	0.04
Aarhus University Hospital, Denmark	1.500000	0.04
University of Copenhagen (UCPH), Denmark	1.333333	0.04
Randers Hospital, Denmark	1.000000	0.03
Herlev University Hospital, Denmark	1.000000	0.03
Gentofte University Hospital, Denmark	1.000000	0.03
Hvidovre Hospital, Denmark	1.000000	0.03
University of Southern Denmark (SDU), Denmark	1.000000	0.03
Danish Colorectal Cancer Center South, Denmark	0.500000	0.01
University of Aalborg (AAU), Denmark	0.500000	0.01
Aarhus University (AU), Denmark	0.500000	0.01

Interested in Oncology and Carcinogenesis?